Abstract

Ferroptosis is a novel type of cell death with distinct properties and recognizing functions involved in physical conditions or various diseases including cancers. The fast-growing studies of ferroptosis in cancer have boosted a perspective for its usage in cancer therapeutics. Here, we review the current findings of ferroptosis regulation and especially focus on the function of ncRNAs in mediating the process of cell ferroptotic death and on how ferroptosis was in relation to other regulated cell deaths. Aberrant ferroptosis in diverse cancer types and tissues were summarized, and we elaborated recent data about the novel actors of some “conventional” drugs or natural compounds as ferroptosis inducers in cancer. Finally, we deliberate future orientation for ferroptosis in cancer cells and current unsettled issues, which may forward the speed of clinical use of ferroptosis induction in cancer treatment.

Keywords

HematologyCancerInternal medicineMedicineOncologyCancer research

MeSH Terms

Cell DeathFerroptosisHumansNeoplasms

Affiliated Institutions

Related Publications

Publication Info

Year
2019
Type
review
Volume
12
Issue
1
Pages
34-34
Citations
1807
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1807
OpenAlex
18
Influential

Cite This

Yanhua Mou, Jun Wang, Jinchun Wu et al. (2019). Ferroptosis, a new form of cell death: opportunities and challenges in cancer. Journal of Hematology & Oncology , 12 (1) , 34-34. https://doi.org/10.1186/s13045-019-0720-y

Identifiers

DOI
10.1186/s13045-019-0720-y
PMID
30925886
PMCID
PMC6441206

Data Quality

Data completeness: 90%